These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10706882)

  • 21. Detection of Fas and its ligand, FasL, in mouse thymus by in situ hybridization.
    Gienau M; Hartmann KU
    Thymus; 1997; 24(4):279-86. PubMed ID: 9493289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Nef-mediated AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with increased Fas/FasL expression on T cells and T-cell death but is not prevented in Fas-, FasL-, tumor necrosis factor receptor 1-, or interleukin-1beta-converting enzyme-deficient or Bcl2-expressing transgenic mice.
    Priceputu E; Rodrigue I; Chrobak P; Poudrier J; Mak TW; Hanna Z; Hu C; Kay DG; Jolicoeur P
    J Virol; 2005 May; 79(10):6377-91. PubMed ID: 15858021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Death of solid tumor cells induced by Fas ligand expressing primary myoblasts.
    Hofmann A; Blau HM
    Somat Cell Mol Genet; 1997 Jul; 23(4):249-57. PubMed ID: 9542527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Egr-2 in up-regulation of Fas ligand in normal T cells and aberrant double-negative lpr and gld T cells.
    Mittelstadt PR; Ashwell JD
    J Biol Chem; 1999 Jan; 274(5):3222-7. PubMed ID: 9915863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fas and Fas ligand expressed on cells of the immune system, not on the target tissue, control induction of experimental autoimmune uveitis.
    Wahlsten JL; Gitchell HL; Chan CC; Wiggert B; Caspi RR
    J Immunol; 2000 Nov; 165(10):5480-6. PubMed ID: 11067900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fas ligand (gld)- and Fas (lpr)-deficient mice do not show alterations in the extravasation or apoptosis of inflammatory neutrophils.
    Fecho K; Cohen PL
    J Leukoc Biol; 1998 Sep; 64(3):373-83. PubMed ID: 9738665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fas-FasL interaction involved in pathogenesis of ocular toxoplasmosis in mice.
    Hu MS; Schwartzman JD; Yeaman GR; Collins J; Seguin R; Khan IA; Kasper LH
    Infect Immun; 1999 Feb; 67(2):928-35. PubMed ID: 9916110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crucial Fas-Fas ligand interaction in spontaneous acceptance of hepatic allografts in mice.
    Uchiyama H; Kishihara K; Minagawa R; Hashimoto K; Sugimachi K; Nomoto K
    Immunology; 2002 Apr; 105(4):450-7. PubMed ID: 11985665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fas system-mediated apoptosis suppresses lymphopoiesis.
    Yasutomo K; Nagasawa H; Hisaeda H; Good RA; Kuroda Y; Himeno K
    J Immunol; 1996 Sep; 157(5):1981-6. PubMed ID: 8757318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fas-Fas ligand-based interactions between tumor cells and tumor-specific cytotoxic T lymphocytes: a lethal two-way street.
    Zeytun A; Hassuneh M; Nagarkatti M; Nagarkatti PS
    Blood; 1997 Sep; 90(5):1952-9. PubMed ID: 9292529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Up-regulation by ammonium trichloro(dioxoethylene-0,0') tellurate (AS101) of Fas/Apo-1 expression on B16 melanoma cells: implications for the antitumor effects of AS101.
    Kalechman Y; Strassmann G; Albeck M; Sredni B
    J Immunol; 1998 Oct; 161(7):3536-42. PubMed ID: 9759874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological and pathological consequences of mutations in both Fas and Fas ligand.
    Weintraub JP; Godfrey V; Wolthusen PA; Cheek RL; Eisenberg RA; Cohen PL
    Cell Immunol; 1998 May; 186(1):8-17. PubMed ID: 9637760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fas-mediated liver damage in MRL hemopoietic chimeras undergoing lpr-mediated graft-versus-host disease.
    Bobé P; Bonardelle D; Reynès M; Godeau F; Mahiou J; Joulin V; Kiger N
    J Immunol; 1997 Nov; 159(9):4197-204. PubMed ID: 9379013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aberrant expression and dysfunction of Fas antigen in MRL/MpJ-lpr/lpr murine ovary.
    Xu JP; Li X; Mori E; Guo MW; Mori T
    Zygote; 1998 Nov; 6(4):359-67. PubMed ID: 9921647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of autoimmune diabetes by Fas ligand: the paradox is solved.
    Kim S; Kim KA; Hwang DY; Lee TH; Kayagaki N; Yagita H; Lee MS
    J Immunol; 2000 Mar; 164(6):2931-6. PubMed ID: 10706679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gammadelta T cells promote a Th1 response during coxsackievirus B3 infection in vivo: role of Fas and Fas ligand.
    Huber S; Shi C; Budd RC
    J Virol; 2002 Jul; 76(13):6487-94. PubMed ID: 12050361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of doxorubicin-induced Fas expression in the antitumor effect of doxorubicin on Lewis lung carcinoma in vivo.
    Yoshimoto Y; Kawada M; Ikeda D; Ishizuka M
    Int Immunopharmacol; 2005 Feb; 5(2):281-8. PubMed ID: 15652759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Constitutive activation of the aryl hydrocarbon receptor in T-lineage cells induces thymus involution independently of the Fas/Fas ligand signaling pathway.
    Nagai H; Kubo M; Abe R; Yamamoto M; Nohara K
    Int Immunopharmacol; 2006 Feb; 6(2):279-86. PubMed ID: 16399633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A role for the Fas/Fas ligand apoptotic pathway in regulating myeloid progenitor cell kinetics.
    Alenzi FQ; Marley SB; Lewis JL; Chandrashekran A; Warrens AN; Goldman JM; Gordon MY
    Exp Hematol; 2002 Dec; 30(12):1428-35. PubMed ID: 12482505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fas/FasL play a central role in pancreatitis-induced hepatocyte apoptosis.
    Gallagher SF; Peng Y; Haines K; Baksh K; Epling-Burnette PK; Yang J; Murr MM
    J Gastrointest Surg; 2005 Apr; 9(4):467-74; discussion 474-5. PubMed ID: 15797225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.